These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18191614)

  • 21. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
    Day C; Ross J; Dolan K
    Drug Alcohol Rev; 2003 Sep; 22(3):317-21. PubMed ID: 15385226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.
    Zeiler I; Langlands T; Murray JM; Ritter A
    Drug Alcohol Depend; 2010 Aug; 110(3):228-33. PubMed ID: 20430537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.
    Hagan H; Des Jarlais DC; Stern R; Lelutiu-Weinberger C; Scheinmann R; Strauss S; Flom PL
    Int J Drug Policy; 2007 Oct; 18(5):341-51. PubMed ID: 17854721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS).
    Murphy EL; Bryzman SM; Glynn SA; Ameti DI; Thomson RA; Williams AE; Nass CC; Ownby HE; Schreiber GB; Kong F; Neal KR; Nemo GJ
    Hepatology; 2000 Mar; 31(3):756-62. PubMed ID: 10706569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands.
    van de Laar TJ; Langendam MW; Bruisten SM; Welp EA; Verhaest I; van Ameijden EJ; Coutinho RA; Prins M
    J Med Virol; 2005 Dec; 77(4):509-18. PubMed ID: 16254983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.
    Currie SL; Ryan JC; Tracy D; Wright TL; George S; McQuaid R; Kim M; Shen H; Monto A
    Drug Alcohol Depend; 2008 Jan; 93(1-2):148-54. PubMed ID: 17977668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus among genitourinary clinic attenders in Scotland: unlinked anonymous testing.
    Goldberg D; Cameron S; Sharp G; Burns S; Scott G; Molyneaux P; Scoular A; Downie A; Taylor A
    Int J STD AIDS; 2001 Jan; 12(1):17-21. PubMed ID: 11177477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Backmund M; Reimer J; Meyer K; Gerlach JT; Zachoval R
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S330-5. PubMed ID: 15768343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.
    Amon JJ; Garfein RS; Ahdieh-Grant L; Armstrong GL; Ouellet LJ; Latka MH; Vlahov D; Strathdee SA; Hudson SM; Kerndt P; Des Jarlais D; Williams IT
    Clin Infect Dis; 2008 Jun; 46(12):1852-8. PubMed ID: 18462109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV prevalence among injection drug users in rural Guangxi China.
    Liu W; Chen J; Rodolph M; Beauchamp G; Mâsse B; Wang S; Li R; Ruan Y; Zhou F; Leung MK; Lai S; Shao Y; Jackson JB
    Addiction; 2006 Oct; 101(10):1493-8. PubMed ID: 16968351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV and HCV testing for young drug users in Rhode Island.
    Pugatch D; Anderson BJ; O'Connell JV; Elson LC; Stein MD
    J Adolesc Health; 2006 Mar; 38(3):302-4. PubMed ID: 16488833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexual activity as a risk factor for hepatitis C in Puerto Rico.
    De Jesús-Caraballo J; Toro DH; Rodríguez-Pérez F; Ruiz H; Dueño MI; Alvarez M; Suárez-Pérez E;
    Bol Asoc Med P R; 2008; 100(3):15-20. PubMed ID: 19227710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.
    Sutton AJ; Hope VD; Mathei C; Mravcik V; Sebakova H; Vallejo F; Suligoi B; Brugal MT; Ncube F; Wiessing L; Kretzschmar M
    J Viral Hepat; 2008 Nov; 15(11):809-16. PubMed ID: 18761605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.